参考文献
(在框内滑动手指即可浏览)
[1] American Cancer Society. Quick facts thyroid cancer [M]. Atlanta:American Cancer Society,2009:1-131.
[2] 郑荣寿,孙可欣,张思维,等. 2015年中国恶性肿瘤流行情况分析[J] . 中华肿瘤杂志,2019,41(1):19-28。
[3] Chen W,Zheng R,Zhang S,et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level [J]. Chin J Cancer Res,2017,29(1):1-10.
[4] Kondo T,Ezzat S,Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia[J]. Nature Reviews Cancer,2006,6:292-306.
[5] Bilimoria KY,Bentrem DJ,Ko CY,et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg,2007,246(3):375-384.
[6] Haugen BR,Alexander EK,Bible KC,et al. 2015 American thyroid association management guidelines for adult satients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2016,26(1):1-133.
[7] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会,中国医学装备协会外科装备分会甲状腺外科装备委员会. 超声引导下甲状腺结节细针穿刺活检专家共识及操作指南(2018版)[J]. 中国实用外科杂志,2018,38(3):241-244.
[8] 中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中国肿瘤临床,2012,39(17):1249-1272.
[9] Nikiforova MN,Wald AI,Roy S,et al. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer[J]. J Clin Endocrinol Metab,2013,98:E1852-E1860.
[10] 中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版)[J]. 中华普通外科学文献(电子版),2019,13(1):1-15.
[11] Vaisman F,Shaha A,Fish S,et al. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer[J]. Clin Endocrinol (Oxf),2011 ,75(1):112-119.
[12] Doi SA,Engel JM,Onitilo AA. Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma[J]. Clin Nucl Med,2010 ,35(6):396-399.
[13] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版)[J]. 中国实用外科杂志,2017,37(9):985-991.
[14] Moo TA,McGill J,Allendorf J,et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma[J]. World J Surg,2010,34(6):1187-1191.
[15] 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版)[J]. 中国实用外科杂志,2013,33(6):470- 474.
[16] Sun H,Tian W,Jiang K,et al. Clinical guidelines on intraoperative neuromonitoring during thyroid and parathyroid surgery[J]. Ann Transl Med,2015,3(15): 213.
[17] 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识(2017版)[J].中国实用外科杂志,2017,37(11):1243-1249.
[18] 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识[J]. 中国实用外科杂志,2015,35(7):731- 736.
[19] Zhu J,Tian W,Xu Z,et al. Expert consensus statement on parathyroid protection in thyroidectomy[J]. Ann Transl Med,2015,3(16): 230.
[20] 郗洪庆,菅雁兵,陈志达,等. 吲哚菁绿荧光实时成像技术在甲状腺癌根治术淋巴结清扫中的初步应用研究[J]. 中华内分泌外科杂志,2019,13(3):219-223.
[21] Gagner M. Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism[J]. Br J Surg,1996,83(6):875.
[22] Hüscher CS,Chiodini S,Napolitano C,et al. Endoscopic right thyroid lobectomy[J]. Surg Endosc,1997,11(8):877.
[23] Miccoli P,Pinchera A,Cecchini G,et al. Minimally invasive,video-assisted parathyroid surgery for primary hyperparathyroidism[J]. J Endocrinol Invest,1997,20(7):429-430.
[24] 仇明,丁尔迅,江道振,等. 颈部无瘢痕内镜甲状腺瘤切除术一例[J]. 中华普通外科杂志,2002,17(2):127.
[25] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会,海峡两岸医药卫生交流协会海西甲状腺微创美容外科专家委员会,等.经胸前入路腔镜甲状腺手术专家共识(2017版)[J]. 中国实用外科杂志,2017,37(12):1369-1373.
[26] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会. 机器人手术系统辅助甲状腺和甲状旁腺手术专家共识[J].中国实用外科杂志,2016,36(11):1165-1170.
[27] 田文,郗洪庆.重视甲状腺癌多学科综合治疗[J].中国实用外科杂志,2019,39(3):197-199
[28] Hundahl SA,Fleming ID,Fremgen AM,et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S.,1985-1995 [see commetns][J].Cancer,1998,83(12):2638-2648.
[29] American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2009,19(11):1167-1214.
[30] Zeng H,Chen W,Zheng R,et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health,2018,6(5):e555-e567.
[31] National Cancer Institute. SEER cancer statistics factsheets:Thyroid cancer[EB/OL]. [2015-06-17]. http://seer./csr/1975_2011/results_merged/topic_survival.pdf.
[32] Milas Z,Shin J,Milas M. New guidelines for the management of thyroid nodules and differentiated thyroid cancer[J]. Minerva Endocrinol,2011,36(1):53-70.
[33] 田文,郗洪庆,王冰. 重视甲状腺癌术后规范化长期随访[J]. 中国实用外科杂志,2017,37(9):937-940.